Definitions, Phenotypes, and Subphenotypes in Acute Kidney Injury-Moving Towards Precision Medicine

Overview

Journal Nephrology (Carlton)

Specialty Nephrology

Date 2022 Nov 12

PMID 36370326

Authors

Camila Eleuterio Rodrigues

Zoltan H Endre

Affiliations

Soon will be listed here.

Abstract

The current definition of acute kidney injury (AKI) is generic and, based only on markers of function, is unsuitable for guiding individualized treatment. AKI is a complex syndrome with multiple presentations and causes. Targeted AKI management will only be possible if different phenotypes and subphenotypes of AKI are recognised, based on causation and related pathophysiology. Molecular signatures to identify subphenotypes are being recognised, as specific biomarkers reveal activated pathways. Assessment of individual clinical risk needs wider dissemination to allow identification of patients at high risk of AKI. New and more timely markers for glomerular filtration rate (GFR) are available. However, AKI diagnosis and classification should not be limited to GFR, but include tubular function and damage. Combining damage and stress biomarkers with functional markers enhances risk prediction, and identifies a population enriched for clinical trials targeting AKI. We review novel developments and aim to encourage implementation of these new techniques into clinical practice as a strategy for individualizing AKI treatment akin to a precision medicine-based approach.

Citing Articles

Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.

Zarbock A, Forni L, Koyner J, Bell S, Reis T, Meersch M Intensive Care Med. 2024; 50(9):1426-1437.

PMID: 39115567 PMC: 11377501. DOI: 10.1007/s00134-024-07560-y.

Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs.

Lin K, Su C, Chen J, Pan S, Chuang M, Lin C Kidney Res Clin Pract. 2024; 43(4):393-405.

PMID: 38934040 PMC: 11237332. DOI: 10.23876/j.krcp.23.284.

Precision management of acute kidney injury in the intensive care unit: current state of the art.

Stanski N, Rodrigues C, Strader M, Murray P, Endre Z, Bagshaw S Intensive Care Med. 2023; 49(9):1049-1061.

PMID: 37552332 DOI: 10.1007/s00134-023-07171-z.

Neutrophil Gelatinase-Associated Lipocalin Cutoff Value Selection and Acute Kidney Injury Classification System Determine Phenotype Allocation and Associated Outcomes.

Albert A, Radtke S, Blume L, Bellomo R, Haase M, Stieger P Ann Lab Med. 2023; 43(6):539-553.

PMID: 37387487 PMC: 10345176. DOI: 10.3343/alm.2023.43.6.539.

Definitions, phenotypes, and subphenotypes in acute kidney injury-Moving towards precision medicine.

Rodrigues C, Endre Z Nephrology (Carlton). 2022; 28(2):83-96.

PMID: 36370326 PMC: 10100386. DOI: 10.1111/nep.14132.

References

Bonventre J . Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009; 24(11):3265-8. DOI: 10.1093/ndt/gfp010. View

Chawla L, Goldstein S, Kellum J, Ronco C . Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care. 2015; 19:93. PMC: 4344798. DOI: 10.1186/s13054-015-0779-y. View

Motohashi H, Inui K . Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. AAPS J. 2013; 15(2):581-8. PMC: 3675737. DOI: 10.1208/s12248-013-9465-7. View

Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F . Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014; 36(10):1559-63. DOI: 10.3109/0886022X.2014.949764. View

Fuhrman D, Maier P, Schwartz G . Rapid assessment of renal reserve in young adults by cystatin C. Scand J Clin Lab Invest. 2013; 73(4):265-8. PMC: 4115038. DOI: 10.3109/00365513.2013.765964. View

Cruz D, De Cal M, Garzotto F, Perazella M, Lentini P, Corradi V . Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2009; 36(3):444-51. PMC: 2820221. DOI: 10.1007/s00134-009-1711-1. View

Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A . Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 54(6):1012-24. DOI: 10.1053/j.ajkd.2009.07.020. View

Praga M, Gonzalez E . Acute interstitial nephritis. Kidney Int. 2010; 77(11):956-61. DOI: 10.1038/ki.2010.89. View

Pianta T, Endre Z, Pickering J, Buckley N, Peake P . Kinetic Estimation of GFR Improves Prediction of Dialysis and Recovery after Kidney Transplantation. PLoS One. 2015; 10(5):e0125669. PMC: 4418565. DOI: 10.1371/journal.pone.0125669. View

10.

Endre Z, Pickering J, Walker R, Devarajan P, Edelstein C, Bonventre J . Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011; 79(10):1119-30. PMC: 3884688. DOI: 10.1038/ki.2010.555. View

11.

Andrade L, Rodrigues C, Gomes S, Noronha I . Acute Kidney Injury as a Condition of Renal Senescence. Cell Transplant. 2018; 27(5):739-753. PMC: 6047270. DOI: 10.1177/0963689717743512. View

12.

Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw S, Bell M . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17(1):R25. PMC: 4057242. DOI: 10.1186/cc12503. View

13.

Vaidya V, Waikar S, Ferguson M, Collings F, Sunderland K, Gioules C . Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2009; 1(3):200-8. PMC: 2638059. DOI: 10.1111/j.1752-8062.2008.00053.x. View

14.

Chung E, Trinh K, Li J, Hahn S, Endre Z, Rogers N . Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics. Front Cardiovasc Med. 2022; 9:868658. PMC: 9163439. DOI: 10.3389/fcvm.2022.868658. View

15.

Kellum J, Sileanu F, Murugan R, Lucko N, Shaw A, Clermont G . Classifying AKI by Urine Output versus Serum Creatinine Level. J Am Soc Nephrol. 2015; 26(9):2231-8. PMC: 4552117. DOI: 10.1681/ASN.2014070724. View

16.

Basu R, Wong H, Krawczeski C, Wheeler D, Manning P, Chawla L . Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery. J Am Coll Cardiol. 2014; 64(25):2753-62. PMC: 4310455. DOI: 10.1016/j.jacc.2014.09.066. View

17.

Basu R, Zappitelli M, Brunner L, Wang Y, Wong H, Chawla L . Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2013; 85(3):659-67. PMC: 4659420. DOI: 10.1038/ki.2013.349. View

18.

Nejat M, Hill J, Pickering J, Edelstein C, Devarajan P, Endre Z . Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant. 2011; 27 Suppl 3:iii96-103. DOI: 10.1093/ndt/gfr222. View

19.

Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase M, Hsieh L . Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol. 2014; 35:143-51. PMC: 4057019. DOI: 10.1016/j.matbio.2014.01.010. View

20.

Toth-Manikowski S, Sirich T, Meyer T, Hostetter T, Hwang S, Plummer N . Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. 2019; 35(5):846-853. PMC: 7203561. DOI: 10.1093/ndt/gfz042. View